Exane Derivatives’s United States Brent Oil Fund BNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-79
Closed -$2.36K – 818
2022
Q1
$2.36K Buy
+79
New +$2.11K ﹤0.01% 741
2021
Q4
– Sell
-79
Closed -$1.63K – 891
2021
Q3
$1.63K Sell
79
-3,211
-98% -$60.9K ﹤0.01% 818
2021
Q2
$64.8K Sell
3,290
-49,098
-94% -$862K 0.01% 607
2021
Q1
$832K Sell
52,388
-35,108
-40% -$538K 0.24% 93
2020
Q4
$1.13M Sell
87,496
-23,955
-21% -$272K 0.33% 71
2020
Q3
$1.19M Sell
111,451
-58,517
-34% -$657K 0.34% 62
2020
Q2
$1.83M Buy
169,968
+100,768
+146% +$921K 0.49% 66
2020
Q1
$546K Buy
+69,200
New +$1.12M 0.15% 115

Other funds holding BNO

Exane Derivatives's BNO Position: Q2 2022 in Review

Exane Derivatives sold out of United States Brent Oil Fund (BNO) in Q2 2022, closing a stake of 79 shares — an estimated $2.36K sold.

Exane Derivatives first reported a position in BNO in Q1 2020 and held it in 8 quarters. The position peaked at $1.83M in Q2 2020. 52 funds tracked by Wall St. Rank hold BNO as of Q2 2022.

  • Exane Derivatives reported no remaining United States Brent Oil Fund position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 79 United States Brent Oil Fund shares in Q2 2022, an estimated $2.36K.
  • Exane Derivatives first reported a position in United States Brent Oil Fund in Q1 2020 and held it in 8 quarters.
  • Exane Derivatives's United States Brent Oil Fund position peaked at $1.83M in Q2 2020.
  • 52 funds tracked by Wall St. Rank held United States Brent Oil Fund as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.